Chemotherapy intensity and toxicity among black and white women with advanced and recurrent endometrial cancer^†‡§¶

A Gynecologic Oncology Group Study

1. John H. Farley MD^1,‖,*,
2. Chunqiao Tian MS²,
3. G. Scott Rose MD¹,
4. Carol L. Brown MD³,
5. Michael Birrer MD, PhD⁴,
6. John I. Risinger PhD⁵,
7. J. Tate Thigpen MD⁶,
8. Gini F. Fleming MD⁷,
9. Holly H. Gallion MD⁸,
10. G. Larry Maxwell MD⁹

Article first published online: 18 NOV 2009

DOI: 10.1002/cncr.24769

Copyright © 2009 American Cancer Society

Issue

1. ^†

   Portions of this report were presented at the Thirty-Ninth Annual Meeting of the Society of Gynecologic Oncologists, held in Tampa, Florida, 2008, and published in Gynecologic Oncology 2008;108:S1, S19.

2. ^‡

   The views expressed herein are those of the authors and do not reflect the official policy or opinion of the Department of Defense or the United States Army or Navy.

3. ^§

   The study was presented to and approved by local institutional review boards before activation, and all patients provided written consent before enrollment on the study.

4. ^¶

   The following Gynecologic Oncology Group member institutions participated in the primary treatment studies: Wake Forest University School of Medicine, Columbus Cancer Council, University of California Medical Center at Irvine, Duke University Medical Center, Wayne State University, Indiana University Medical Center, University of Kentucky, Washington University School of Medicine, Abington Memorial Hospital, University of Iowa Hospitals and Clinics, Tufts-New England Medical Center, University of Mississippi Medical Center, Milton S. Hershey Medical Center, Rush-Presbyterian-St. Luke's Medical Center, Albany Medical College, University of Texas Southwestern Medical Center at Dallas, Community Clinical Oncology Program, University of Oklahoma, University of Minnesota Medical School, University of Virginia, The Cleveland Clinic Foundation, University of Alabama at Birmingham, Colorado Gynecologic Oncology Group, University of North Carolina School of Medicine, University of Massachusetts Medical School, Fox Chase Cancer Center, Women's Cancer Center, SUNY at Stony Brook, Medical University of South Carolina, Johns Hopkins Oncology Center, Cooper Hospital/University Medical Center, University of Chicago, Walter Reed Army Medical Center, Tampa Bay Cancer Consortium, University of Rochester Medical Center, Eastern Pennsylvania GYN/ONC Center, Tacoma General Hospital, Thomas Jefferson University Hospital, Case Western Reserve University, University of Cincinnati, University of Pennsylvania Cancer Center, Gynecologic Oncology Network, Georgetown University Hospital, Mayo Clinic, Oregon Health Sciences University, University of Miami School of Medicine, University of California at Los Angeles, SUNY Upstate Medical Center, Eastern Virginia Medical School, M.D. Anderson Cancer Center, Ellis Fischel Cancer Center, SUNY Downstate Medical Center, Emory University Clinic, University of Southern California at Los Angeles, Stanford University Medical Center, Memorial Sloan-Kettering Cancer Center, University of Washington, North Shore University Hospital, and Long Island Jewish Medical Center.